Funding round
Essential Pharma Growth
Reported as "Growth Equity"
Essential Pharma, which works in specialty pharmaceutical development in Egham, raised $946M in a Growth round announced on 12 Dec 2024, led by AlpInvest. 3 firms took part.
$946M
Amount raised
900,000,000 EUR converted
Not disclosed
Post-money valuation
3
Investors
1 lead
Valuation
What this round says about the price
Essential Pharma did not disclose a valuation in this round. It is Essential Pharma's first venture round on record, 24 years after it was founded in 2000. No later venture round is on record for Essential Pharma.
Essential Pharma's funding rounds
This is the only venture round on record for Essential Pharma.
- Growth this round 12 Dec 2024, led by AlpInvest $946M
Investors
Who put money in
AlpInvest led the round with 2 other firms.
Lead investor
- AlpInvest new investor
Also in the round
- backs 2 venture-backed companies new investor
- Sixth Street backs 34 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, geographic expansion, scaling operations, acquisitions and working capital.
- Product development
- Geographic expansion
- Scaling operations
- Acquisitions
- Working capital
Comparable rounds
How it compares
32 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $46M, and this round was 21 times the median. The closest in time, other companies' Growth rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Pharmaceutical Products | 4 Dec 2024 | undisclosed | not disclosed | Ampersand Capital Partners |
| Pharmaceutical Products | 13 Jan 2025 | $100M | $1.40B | Quadria Capital |
| Pharmaceutical Products | 28 Jan 2025 | $30M | not disclosed | Columbus Venture Partners and Pontifax Venture Capital |
| Pharmaceutical Products | 7 Jan 2025 | $29M | $117M | Stakeboat Capital |
| Pharmaceutical Products | 11 Oct 2024 | $7.3M | not disclosed | West Hill Capital |
| Pharmaceutical Products | 29 Oct 2024 | undisclosed | not disclosed | 1315 Capital |
| Pharmaceutical Products | 17 Sep 2024 | $200M | not disclosed | Bain Capital Life Sciences |
| Pharmaceutical Products | 1 Mar 2025 | $60M | not disclosed | not named |
Sources
Where this comes from
Reported by 5 sources.
Questions
Frequently asked
How much did Essential Pharma raise in its Growth round?
Essential Pharma raised $946M in its Growth round, announced in Dec 2024.
Who led Essential Pharma's Growth round?
AlpInvest led it, with Gyrus Capital and Sixth Street.
What was Essential Pharma's valuation at the Growth round?
It was not disclosed.
How does it compare with other Growth rounds in Pharmaceutical Products?
32 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $46M, and this round was 21 times the median.